Faes Farma SA - Company Profile

Powered by

All the data and insights you need on Faes Farma SA in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Faes Farma SA Strategy Report

  • Understand Faes Farma SA position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Faes Farma SA: Overview

Select Item

Faes Farma SA (Faes Farma) develops, manufactures, and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, generic drugs, food supplements, over the counter (OTC) medications, baby foods, skin-care treatment products. It exports raw materials and finishes pharmaceutical products to pharmaceutical companies worldwide. Faes Farma also owns animal nutrition and healthcare company such as Ingaso farm. The company operates manufacturing and R&D center in Leioa, Spain, laboratory, production plants, subsidiaries, and commercial offices in international markets. The company markets the products in Latin America, Asia, Europe, Africa, and the Middle East. Faes Farma is headquartered in Leioa, Spain.

 Gain a 360-degree view of Faes Farma SA and make more informed decisions for your business Gain a 360-degree view of Faes Farma SA and make more informed decisions for your business Find out more
Headquarters Spain
Address Edificio 2, 2 Izquierda, Madrid, 28033
Website faesfarma.com
Telephone 34 914 680800
No of Employees 1,748
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange FAE (MCE)
Revenue (2022) $487.9M 2.8% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 2.6% (2022 vs 2021)
Market Cap* $1.1B
Net Profit Margin (2022) XYZ -0.2% (2022 vs 2021)
* As of and is in US$
View Faes Farma SA financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Faes Farma SA premium industry data and analytics

50+

Marketed Drugs

Understand Faes Farma SA’s commercialized product portfolio to stay one step ahead of the market.

30+

Clinical Trials

Determine Faes Farma SA go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

9

Pipeline Drugs

Identify which of Faes Farma SA’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

7

Catalyst Calendar

Proactively evaluate Faes Farma SA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Faes Farma SA’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products
-
Active Ingredients:
Diosmine (CEP)
XYZ
XYZ
XYZ
Understand Faes Farma SA portfolio and identify potential areas for collaboration Understand Faes Farma SA portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Acquisitions/Mergers/Takeovers In March, the company acquired the stakes of NovoSci.
2021 Contracts/Agreements In March, the company signed a contract to acquire Global Farma.
2019 Acquisitions/Mergers/Takeovers In October, the company acquired 100% stake in BCN Medical for EUR20 million.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Faes Farma SA Grifols SA Almirall SA Laboratorios Farmaceuticos Rovi SA Laboratorios Richmond SACIF
Headquarters Spain Spain Spain Spain Argentina
City Madrid Barcelona Barcelona Madrid Buenos Aires
State/Province Madrid Barcelona - Madrid Ciudad Autonoma De Buenos Aires
No. of Employees 1,748 23,744 1,904 2,111 -
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Mariano Ucar Angulo Chairman Executive Board 2013 -
Francisco Perez-Crespo Paya Secretary Senior Management - -
Isidro Hermo Blanco Director Senior Management - -
Ignatius Sancho Martinez Director Senior Management - -
Francisco Perello Source Director Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Faes Farma SA key executives to enhance your sales strategy Gain insight into Faes Farma SA key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward